Scientific, Technical Research and Program Management Support Services for USAMRIID
ID: HT942525R0005Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES (AN14)

Set Aside

8(a) Set-Aside (FAR 19.8) (8A)

Original Source

https://sam.gov/opp/f9039b7ccd64466e8acc0cf990237212/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for scientific and technical research and program management support services for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The procurement aims to enhance research capabilities in biotechnology, specifically focusing on health-related research and development services. This opportunity is critical for advancing the understanding and management of infectious diseases, thereby supporting national health security. Interested parties should note that this is an 8(a) set-aside contract, and inquiries can be directed to Christina Lewis at christina.m.lewis14.civ@health.mil or Jayme Fletcher at jayme.l.fletcher2.civ@health.mil.

    Point(s) of Contact
    Christina Lewis
    christina.m.lewis14.civ@health.mil
    Jayme Fletcher
    jayme.l.fletcher2.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Scientific, Technical Research and Program Management Support Services for USAMRIID
    Currently viewing
    Presolicitation
    Similar Opportunities
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Buyer not available
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    Biomedical Research Application Evaluation and Support Services (BRAES)
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for Biomedical Research Application Evaluation and Support Services (BRAES) to enhance the management of biomedical research applications under the Congressionally Directed Medical Research Programs (CDMRP). The procurement aims to provide comprehensive evaluation services, including compliance reviews, peer review management, and technical support, utilizing advanced systems for application submission and data management. This initiative is crucial for ensuring effective oversight and innovation in biomedical research, particularly for military personnel and the general public. Interested parties can contact Deanna Moose at deanna.s.moose.civ@health.mil or Jeanette Wolfe at jeanette.m.wolfe.civ@health.mil for further details, with proposals due as specified in the attached documents.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Buyer not available
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Solicitation HT942525R0037 - Human Subjects Protection Personnel Mgmt and Support Services - USAMRDC OHARO
    Buyer not available
    The Department of Defense, through the Army Medical Research Acquisition Activity, is soliciting proposals for Human Subjects Protection Personnel Management and Support Services under Solicitation HT942525R0037. The primary objective is to provide comprehensive personnel and non-personal services to support the Office of Human and Animal Research Oversight (OHARO), ensuring compliance with federal and Department of Defense regulations regarding human subjects in research. This initiative is crucial for maintaining high ethical standards and operational efficiency in research involving human subjects, reflecting broader federal commitments to research safety and ethics. Interested contractors can reach out to Alana M. Sowers at alana.m.sowers.civ@health.mil for further details, with the contract structured over a 12-month base period and optional extensions, emphasizing fixed firm pricing for various support services.
    Notice of Intent to Sole Source ‘omics analyses
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), has issued a Special Notice regarding its intent to sole source ‘omics analyses services. The procurement aims to secure specialized research and development services in the life sciences sector, specifically focusing on health-related research and applied analysis. These services are critical for advancing health care solutions and enhancing the understanding of biological systems, which are vital for military health initiatives. Interested parties can reach out to Kasey Carroll at kasey.l.carroll.civ@health.mil or Courtney Piar at courtney.a.piar.civ@health.mil for further information regarding this opportunity.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
    Buyer not available
    Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
    Remote Health Readiness Program 4 (RHRP-4)
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for the Remote Health Readiness Program 4 (RHRP-4), which aims to provide comprehensive medical and dental readiness services to military personnel, including both active duty and reserve components. The contract, valued at up to $1.61 billion, will be structured as an Indefinite Delivery Indefinite Quantity (IDIQ) contract over a ten-year period, encompassing a transition phase followed by a base period and nine optional years of performance. This initiative is crucial for maintaining the health and operational readiness of service members, ensuring they receive necessary assessments and treatments across various modalities, including in-clinic and virtual care. Interested contractors should contact Nakaura C. Yusuf at nakaura.c.yusuf.civ@health.mil or call 703-681-5821 for further details regarding the solicitation process.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Buyer not available
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
    vitro diagnostic substances, reagents, test kits and sets
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is seeking proposals for a Women-Owned Small Business (WOSB) contract focused on procuring in-vitro diagnostic substances, reagents, and test kits, specifically targeting Biofire Defense products. This procurement is critical for developing reagents used in biological defense against warfare agents, with a total contract value of $64,978.00 for the unique 10x Buffer with BSA 50mM Mg2Cl2, which is essential for operational effectiveness. Interested vendors must submit their offers by March 8, 2025, at 2:00 PM local time, and can direct inquiries to Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or 301-319-9948.
    In Vitro Assessments of Antimicrobial Activity
    Buyer not available
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the In Vitro Assessments of Antimicrobial Activity (IVAAA) program through solicitation RFP 75N93024R00024. This initiative aims to support in vitro testing to evaluate the therapeutic potential of compounds against over 270 infectious agents, facilitating the development of vaccines, therapeutics, and diagnostics for infectious diseases. The program is critical for enhancing public health preparedness and response capabilities, particularly in addressing emerging health threats such as bioterrorism and infectious diseases. Proposals are due by March 10, 2025, with a funding range of $2,500 to $15 million available through January 14, 2033. Interested parties can direct inquiries to Alexander Beraud at alexander.beraud@nih.gov or Brian Madgey at brian.madgey@nih.gov.